HAEMONETICS CORPORATION (HAE) Operating income 2017–2026
HAEMONETICS CORPORATION (HAE) annual operating income history from SEC filings — each fiscal year as reported.
$156.7MFY2026 · since FY2017: -$19.4M → $156.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $156.7M | -29.3% |
| FY2025 | $221.8M | +34.5% |
| FY2024 | $164.9M | +5.7% |
| FY2023 | $156.0M | +93.2% |
| FY2022 | $80.8M | -10.0% |
| FY2021 | $89.7M | -13.2% |
| FY2020 | $103.4M | +23.7% |
| FY2019 | $83.5M | +48.8% |
| FY2018 | $56.2M | +389.8% |
| FY2017 | -$19.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice